Released: December 07, 2023

White House targets drug patents to lower prices

Source: Washington Post staff (Paid Registration)

The White House announced its latest gambit to lower U.S. drug prices: a plan to step in and license patent rights to other manufacturers when certain drugs’ prices are too high.

“The agency that funded the research can then license the invention to a competitor that is able and willing to make it available on reasonable terms," said Neera Tanden, director of the White House Domestic Policy Council. "Fundamentally, we are establishing that price can now be a factor in determining … when the federal government can march-in to ensure that we have lower prices.”

 

Read Full Article: White House targets drug patents to lower prices